Cargando…

Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19

The development of biological disease-modifying antirheumatic drugs (bDMARDs) and target synthetic DMARDs (tsDMARDs), also known as small molecule inhibitors, represent a breakthrough in rheumatoid arthritis (RA) treatment. The tsDMARDs are a large family of small molecules targeting mostly the seve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Massalska, Magdalena, Maslinski, Wlodzimierz, Ciechomska, Marzena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464410/ https://www.ncbi.nlm.nih.gov/pubmed/32796683 http://dx.doi.org/10.3390/cells9081876

Ejemplares similares

Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment
por: Bonek, Krzysztof, et al.
Publicado: (2021)

DNA Methylation as a Future Therapeutic and Diagnostic Target in Rheumatoid Arthritis
por: Ciechomska, Marzena, et al.
Publicado: (2019)

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
por: Bonek, Krzysztof, et al.
Publicado: (2022)

Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients
por: Ciechomska, Marzena, et al.
Publicado: (2018)

Different expression of chemokines in rheumatoid arthritis and osteoarthritis bone marrow
por: Kuca-Warnawin, Ewa H., et al.
Publicado: (2016)

Circulating miRNA-19b as a biomarker of disease progression and treatment response to baricitinib in rheumatoid arthritis patients through miRNA profiling of monocytes
por: Ciechomska, Marzena, et al.
Publicado: (2023)

Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients
por: Wroński, Jakub, et al.
Publicado: (2022)

The Kinetics of Humoral and Cellular Responses after the Booster Dose of COVID-19 Vaccine in Inflammatory Arthritis Patients
por: Wroński, Jakub, et al.
Publicado: (2023)

Rheumatoid arthritis bone marrow environment supports Th17 response
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2017)

CD4(+)FOXP3(+) T Cells in Rheumatoid Arthritis Bone Marrow Are Partially Impaired
por: Massalska, Magdalena, et al.
Publicado: (2020)

Tuning Monocytes and Macrophages for Personalized Therapy and Diagnostic Challenge in Rheumatoid Arthritis
por: Roszkowski, Leszek, et al.
Publicado: (2021)

Effectiveness of Soluble CTLA-4-Fc in the Inhibition of Bone Marrow T-Cell Activation in Context of Indoleamine 2.3-Dioxygenase (IDO) and CD4(+)Foxp3(+) Treg Induction
por: Massalska, Magdalena, et al.
Publicado: (2022)

Potential Mechanism of Fatigue Induction and Its Management by JAK Inhibitors in Inflammatory Rheumatic Diseases
por: Felis-Giemza, Anna, et al.
Publicado: (2023)

Cartilage and bone damage in rheumatoid arthritis
por: Ostrowska, Monika, et al.
Publicado: (2018)

Interleukin-15 as a Biomarker Candidate of Rheumatoid Arthritis Development
por: Kurowska, Weronika, et al.
Publicado: (2020)

Circulating tumour necrosis factor-α bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response
por: Marotte, Hubert, et al.
Publicado: (2005)

S100A8 and S100A12 Proteins as Biomarkers of High Disease Activity in Patients with Rheumatoid Arthritis That Can Be Regulated by Epigenetic Drugs
por: Roszkowski, Leszek, et al.
Publicado: (2022)

The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis
por: Kurowska, Weronika, et al.
Publicado: (2017)

Significance of bone marrow edema in pathogenesis of rheumatoid arthritis
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2013)

Different Secretory Activity of Articular and Subcutaneous Adipose Tissues from Rheumatoid Arthritis and Osteoarthritis Patients
por: Plebańczyk, Magdalena, et al.
Publicado: (2018)

Monocyte-related biomarkers of rheumatoid arthritis development in undifferentiated arthritis patients – a pilot study
por: Kurowska, Weronika, et al.
Publicado: (2018)

Role of inflammatory factors and adipose tissue in pathogenesis of rheumatoid arthritis and osteoarthritis. Part I: Rheumatoid adipose tissue
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2013)

Antibodies to Citrullinated Proteins (ACPA) Associate with Markers of Osteoclast Activation and Bone Destruction in the Bone Marrow of Patients with Rheumatoid Arthritis
por: Kurowska, Weronika, et al.
Publicado: (2021)

Significance of Polymorphism and Expression of miR-146a and NFkB1 Genetic Variants in Patients with Rheumatoid Arthritis
por: Bogunia-Kubik, Katarzyna, et al.
Publicado: (2017)

The pathogenesis of rheumatoid arthritis in radiological studies. Part I: Formation of inflammatory infiltrates within the synovial membrane
por: Sudoł-Szopińska, Iwona, et al.
Publicado: (2012)

Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations
por: Ajeganova, Sofia, et al.
Publicado: (2017)

Rheumatiod Arthritis: An Updated Overview of Latest Therapy and Drug Delivery
por: Kesharwani, Disha, et al.
Publicado: (2019)

Toll-like receptor 9 agonists and IL-15 promote activation, proliferation, secretion of proinflammatory cytokines and differentiation of B cells isolated from bone marrow of rheumatoid arthritis patients
por: Rudnicka, W, et al.
Publicado: (2007)

IL-15 and its role in rheumatoid arthritis
por: Kurowska-Stolarska, M, et al.
Publicado: (2003)

The inhibitor of differentiation-2 promotes synovial fibroblast-dependent osteoclastogenesis in rheumatoid arthritis
por: Kurowska-Stolarska, M, et al.
Publicado: (2005)

Small molecule kinase inhibitors alleviate different molecular features of myotonic dystrophy type 1
por: Wojciechowska, Marzena, et al.
Publicado: (2014)

Tocilizumab in the treatment of rheumatoid arthritis and beyond
por: Shetty, Anjali, et al.
Publicado: (2014)

Genetics of rheumatoid arthritis: GWAS and beyond
por: McAllister, Kate, et al.
Publicado: (2011)

New small-molecule drug design strategies for fighting resistant influenza A
por: Shen, Zuyuan, et al.
Publicado: (2015)

Monkeypox and Pregnancy: Latest Updates
por: Cuérel, Alexandre, et al.
Publicado: (2022)

Rituximab for the treatment of rheumatoid arthritis: an update
por: Mok, Chi Chiu
Publicado: (2013)

JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
por: Fragoulis, George E, et al.
Publicado: (2019)

Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity
por: Mielnik, Pawel, et al.
Publicado: (2010)

Distinct lymphocyte subpopulations in bone marrow from rheumatoid arthritis and osteoarthritis patients: a role for IL-15?
por: Maslinski, W, et al.
Publicado: (2004)

Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis C
por: Bell, Allison M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mprd9s7ase79hk9plpiqof8tah